ArticleCancers2021

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3).

Leonidas Apostolidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.